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8534 | Anal. Methods, 2015, 7, 8534–8ispersion assay using tunable
resistive pulse sensing (TRPS)†
E. R. Billinge and M. Platt*Aggregates of micron sized beads were formed by the binding of anti-
thrombin aptamer to its complement. The addition of the thrombin
protein target caused a concentration-dependant dispersion of these
aggregates, and their number was measured by tunable resistive pulse
sensing. The technique allowed the detection of thrombin down to
sub picomolar concentrations, and an increase in sensitivity over
previous assays on the same platform. The sensitivity of the assay is
attributed to each thrombin protein disrupting multiple aggregates
resulting in a signal amplification.In recent decades there has been an increased drive towards the
development of rapid, affordable and user-friendly assay tech-
niques; this has been in part directed by the need to reduce
assay times and widen the availability of assays available for
routine clinical measurements.1–3 Increasingly nanoparticle
based assays are the platform of choice for new sensor tech-
nologies.4 Signicant advancements have been made in
synthesis strategies to selectively modify materials and their
surface chemistries adding protein and DNA capture probes to
enable the development of bioassays.5
The ability of the capture probe to successfully interact with
its target is key to providing an assay which is both selective and
sensitive. Whilst antibodies have remained the capture probe of
choice, aptamer technologies are gaining interest.6 Aptamers
are short single stranded oligonucleotides which are able to
bind to a wide range of targets with high selectivity and speci-
city.7 Aptamers are most commonly generated by a process
known as the Systematic Evolution of Ligands by Exponential
Enrichment (SELEX)8,9 or by Closed Loop Aptameric Directed
Evolution (CLADE).6,10,11 Since their discovery aptamers have
been increasingly integrated into both existing and emerging
sensor platforms – reviews on aptasensors are available.12,13rsity, Loughborough, Leicestershire, LE11
(ESI) available: Materials and methods
ls, supplementary Fig. 1 displaying
y01655j
538Aptamers to thrombin have been widely used to test
emerging sensor technologies. Thrombin is a protein involved
in feedback mechanisms for haemostasis and in the clotting
cascade where it catalyses the formation of brin.14 The
concentration of thrombin must therefore be tightly regulated
by biological systems and monitored as any deviations from
normal physiological concentrations could pose a risk of blood
clot formation leading to heart attack or stroke.15,16 The
thrombin aptamer has a well characterised binding mechanism
and high affinity, making it an ideal protein target to test
emerging sensors.10 Attaching aptamers to nanoparticles allows
the combination of the selectivity of the aptamer capture probe
with established detection methods of nanoparticles.13 Assay
formats include colorimetry,17 lateral ow assays,18 uores-
cence,19 light-scattering20 and electrochemistry21 with detection
levels as low as 100 fM.21
A recent technology that used aptamer modied particles
was pioneered by this laboratory based upon a variation of the
Coulter principle.22–26 Coulter-based technologies, known
collectively as resistive pulse sensing (RPS), are able to provide a
particle-by-particle analysis in situ as individual particles are
driven through pores by a combination of electrophoretic,
electroosmotic and gravitational forces. RPS has been demon-
strated to be useful in many elds, including biological detec-
tion27,28 and particle characterisation.22,26 In brief, a single pore
in a non-conductive membrane separates two electrolyte-lled
uid chambers with electrode in each; the electrodes establish a
stable baseline current and sample is loaded into one of the
uid chambers. As the sample moves through the pore, defor-
mations in the baseline current occur (“blockade events”) as
discussed in more detail elsewhere.29 The use of polyurethane,
elastomeric membranes in conjunction with RPS has allowed
the creation of tunable resistive pulse sensing (TRPS). In TRPS
the pore is able to be mechanically manipulated in real time to
alter pore geometry and investigate a range of particle sizes with
a single pore in addition to allowing signicant optimisation
and the removal of blockages. Images and a schematic of the
instrumentation are displayed in the ESI in Fig. S1.† TRPS hasThis journal is © The Royal Society of Chemistry 2015
Fig. 1 Schematic of assay principles (not to scale). (A) 1 mm SPBs are
coated with thrombin aptamer (purple) and 400 (or 800 nm) beads are
coated with a complementary strand of DNA (green). Aggregates are
formed as complementary DNA binds. (B) With the addition of
thrombin, the aptamer undergoes a conformational change and the
complementary DNA is released. (C) The SPBs are separated by use of
a magnet, leaving the released 400 or 800 nm beads (the dispersant) in
solution for concentration analysis. (D) Example blockades for an 800
nm bead (i), a dynabead (ii) and an aggregate (iii) measured from a
sample of aggregate formation.
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View Article Onlinebeen successfully used to study the concentration,29,30 size31 and
charge32,33 of colloidal dispersions as well as monitoring the
concentration-dependent aggregation of superparamagnetic
beads (SPBs) and the aggregation of nanorods.26
In this assay 1 mm SPBs, (Dynabeads MyOne carboxylic acid)
were coated with amine-terminated anti-thrombin-15 aptamer
(30amine-TTTTTGGTTGGTGTGGTTGG50)35 and either 800 nm or
400 nm carboxyl beads which are not superparamagnetic (Izon
Sciences, CPC800, SKP400) were coated with an amine-termi-
nated complementary sequence to the aptamer (30amine-
TTTTTTTTTCCAACCACA50) as illustrated in Fig. 1. All experi-
ments were conducted in PBST (0.05% Tween-20) buffer unless
otherwise stated. Full materials and methods information is
provided as ESI.† Initially the two bead populations form aggre-
gates through double-stranded DNA. Upon the introduction of
the target protein, the dsDNA structure is disrupted causing the
dispersion of the aggregate. By using two bead populations, the
SPBs with the anti-thrombin aptamer are able to be removed from
the solution by a magnet leaving the dispersed smaller particles
for analysis. A schematic of this assay is illustrated in Fig. 1. The
number of smaller particles that are dispersed increases with
increasing protein concentrations. Herein we present an assay
capable of producing a signal at concentrations as low as 100 fM.
In previous work thrombin was detected down to 1.4 nM
using aptamer modied beads on the TRPS platform.34 In brief,
this previous assay entailed anchoring the aptamer directly to
beads surface measuring the relative change in frequency and
speed at which the particles move through the pore.34 This
approach, while a useful proof-of-concept for the detection of
proteins and for aptamer characterisation, involved measuring
the diminution of the signal with increased concentration of
protein. In addition with the previous method the protein
concentration was measured by monitoring the protein–bead
conjugate, requiringmany proteins to cover the bead to produce
an observable signal. Here proteins that bind to aptamers on
the larger 1 mm SPBs results in the release of several smaller
particles, each individual protein causes a measurable signal
producing a more sensitive assay. This new method is favour-
able for two key reasons: rstly, a positive signal is generated i.e.
increased bead concentration with increased thrombin and
secondly an increase in assay sensitivity was observed due to a
more efficient ratio between protein and measurable signal in
comparison with our previous work.34
To rst conrm that the DNA had been conjugated to the
beads surface, the translocation rate, J, was monitored.
J
C
¼ 3

zparticle  zpore

h
E þ Qp
A
(1)
where C is concentration of particles 3 is permittivity of the
electrolyte buffer, h is viscosity of the medium, E is the applied
electric eld, Qp is the pressure-driven ow, zparticle and zpore
potential are the zeta potential of the particle and pore
respectively, and A is the diameter of the pore constriction.32 z
potential is a function of the surface charge and is used as a
measure of the electrokinetic potential in colloidal systems.
When the pore size, charge, and solution viscosity remain
constant, changes to the blockade frequency, J, can be used toThis journal is © The Royal Society of Chemistry 2015infer a change in surface charge. Thus the addition of DNA onto
the beads surface should cause an increase in blockade
frequency.Anal. Methods, 2015, 7, 8534–8538 | 8535
Fig. 3 (A) Size histogram for a sample of CPC800s incubated with
Dynabead MyOne beads. Inset: CPC800s (black) and SPBs (blue) prior
to incubation together. (B) Percentage of blockades recorded as either
monomers (black columns) or aggregates (white columns with black
outline) for a dynabead sample, dynabead and 800 nm particles
without overnight incubation in fridge, dynabeads and 800 nm and
400 nm beads which were left to mix for 30 minutes before being
placed upright in a fridge for 24 hours.
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View Article OnlineThe blockade frequencies of DNA modied and unmodied
beads were measured under several voltage biases, Fig. 2. Using
the relationship between J and V it was possible to get qualita-
tive information that the DNA was present on the beads surface:
DNA loading onto the beads increases the negative surface
charge density, thereby increasing the rate (particles per min) of
beads traversing the pore as well as the gradient when plotting J
versus V. This same technique was also used to verify the
immobilisation of the aptamer and the partial complementary
sequences on the smaller beads.
To form SPB beads loaded with their smaller particle payload,
the two bead populations are mixed together. Initially 1  109 1
mm beads per mL were mixed with 8 109 800 nm beads per mL
on a rotary wheel for 30minutes. This mixing alone was found to
form insufficient aggregate numbers, Fig. 3, and to increase the
numbers of aggregates aer the initial 30 minute incubation the
samples were then stored for a 24 hour period, upright in the
fridge. An alternative bead size was prepared under the same
conditions, containing 1  109 1 mm beads per mL and 5  1010
400 nm beads per mL to investigate the effect of bead size of the
dispersant on this aptamer-based assay.
Two methods were used to verify the formation of aggre-
gates. Firstly by measuring an increase in blockade magnitude
as displayed in Fig. 3A, aggregates typically produce a signal
>0.66 nA. As the blockade magnitude is proportional to the
volume of the object moving through the pore, it is possible to
estimate the number of beads in each aggregate, the modal
aggregate size suggested that the aggregates comprised of 2.9 
800 nm bead per dynabead or 15 400 nm beads per dynabead.
This is likely to be an underestimation of the number and size
of the aggregates as larger clusters could be excluded from the
analysis as they are unable to traverse the pore opening.
Further conrmation that the 1 mm beads had picked up
their smaller particle cargo was done by simply counting a
decrease in the concentration of smaller beads. The total
concentration of particles moving through the pore decreases as
they form clusters. For the 800 nm particles the concentration
of particles in solution had decreased to 2.6  109 beads per mL
from 8  109 beads per mL, whereas the 400 nm the concen-
tration had decreased to 1.3 109 beads per mL from 5.1 1010
beads per mL. This decrease in concentration suggests thatFig. 2 Plots of observed particle rate vs. applied voltage for beads with
and without DNA. Black lines correspond to CPC800 beads and red
lines to dynabeads both analysed using an np 1000 pore at 47 mm
stretch. Circles represent results from blank beads, whilst crosses
represent beads which had undergone DNA functionalization.
8536 | Anal. Methods, 2015, 7, 8534–8538aggregates have been successfully formed, and these gures as
shown as a percentage in Fig. 3B. Based upon these numbers an
alternative calculation can then be done to determine the
average number of smaller beads per dynabead based upon the
particle concentrations before and aer incubation. This yiel-
ded a mean number smaller beads per dynabead of 5.4  800
nm beads or 49  400 nm beads.
The discrepancy between the two techniques is most likely
be due to a lack of resolution for the pore to successfully resolve
the binding of individual beads, and/or the occlusion of some of
the larger aggregates due to size.
Following the formation of aggregates the prepared bead
mixtures were washed by magnetic separation four times and
then incubated with varying concentrations of thrombin
(thrombin from bovine plasma, Sigma Aldrich) or when a blank
control experiment was required with BSA. Aer 30 minutes the
samples were placed into a MagRack until a cluster was visible
on the side of the vials (5 minutes) and the supernatant carefully
removed to a clean sample vial (Fig. 1C). The concentration of
the non-superparamagnetic 800 nm or 400 nm beads within the
blank was then also measured, to determine the number of
dispersant beads released in the absence of the target, data
shown in Fig. 4 and separately displayed in Fig. S2.† The
sensitivity of this assay relies upon the ability of TRPS to accu-
rately count dispersed beads. To illustrate the sensitivity of theThis journal is © The Royal Society of Chemistry 2015
Fig. 4 Concentration of 800 nm beads (black circles) or 400 nm
beads (red diamonds) dispersed by thrombin with increasing thrombin
concentration. Data shown represents the mean value obtained from
four repeat experiments with error bars representing 1 standard
deviation from the mean. In each concentration of thrombin the
number of dynabeads was the same for both the 400 and 800
aggregates.
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View Article Onlinesystem in its current conguration a calibration curve was
constructed, and is shown in Fig. S3.† The LOD measured by
TRPS is highly dependent on the pore size, applied voltage, and
pressure. The applied voltage was chosen to be sufficient to
observe the particle above the level of baseline noise whilst not
causing an increase in baseline noise. The pore size was chosen
to allow a clear signal for the beads, and a pressure of 5 cm H2O
was applied to decrease the sample capture time and increase
sensitivity of the concentration calibrations. The calibration
curve was conducted under the same TRPS conditions used for
Fig. 4.
Fig. 4 displays the data for both bead sizes, and illustrates
that as the concentration of thrombin increases so does the
number of dispersed beads. By dividing the number of proteins
by the number of dynabeads it is possible to calculate a ratio of
proteins : particle and is listed in Table 1. As each thrombin
protein collides with a dynabead it disrupts the dsDNA and
stimulates the release of the smaller particles into solution. The
interaction of the aptamer and its target is dynamic, and the
protein is likely to dissociate from its aptamer and be released
back into solution where is can bind to another aptamer, most
likely on the same dynabead. The authors acknowledge that the
number of aptamers on each dynabead will greatly outnumber
the number of proteins. If the protein stays associated with theTable 1 Table displaying the number of thrombin molecules in solution
the small particle payload released by the thrombin addition
Thrombin concentration
(pM)
Ratio of thrombin
proteins per dynabead
0 0
0.1 0.06
1 0.6
5 3
10 6
This journal is © The Royal Society of Chemistry 2015dynabeads it rst makes contact with, it has the opportunity to
bind and then dissociate with multiple aptamers on the same
bead. As such a lot of protein–aptamer interactions will not
cause the release of a smaller bead. But eventually as the protein
moves across the particles surface more than one dsDNA
interaction will be disrupted. Therefore the magnitude, and
speed at which all the particles are dispersed from the dynabead
resulting in the “amplication” may well be related to the
dissociation rate and as such other targets may not produce the
same amplication factor.
As the number of beads attached to the dynabeads is nite,
as the amount of thrombin increases the curve reaches a
maximum which represents all of the smaller beads released
from the surface. The percentage of particles released, listed in
Table 1, was calculated as the ratio between the number of
observed particles divided by the total number of particles
observed at 10 pM thrombin.
From Fig. 4 it is apparent that a greater concentration of 400
nm beads are ejected from the dynabeads in solution than the
800 nm beads, although there was minimal difference in the
blank values. It was hypothesised that this is due to their
smaller size therefore more 400 nm beads would be able to t
around each individual dynabead. Calculations show that the
surface area of the dynabeads is large enough to bind to circa 33
 400 nm particles, and as indicated by the measured values
above the TRPS system does not seem capable of measuring
such small volume changes. However this increased number of
smaller beads per dynabead leads to the release of a larger
number of particles per thrombin protein. As we observe from
the shape of the concentration curves using the 400 nm beads
appears to increase the dynamic range of the assay.
To ensure that the dispersion of the non-SPBs was due to the
specic thrombin–aptamer interaction, formed aggregates were
also incubated with 3 mM bovine serum albumin solution
(Sigma Aldrich, UK). Addition of non-specic protein did not
result in any deviation from the measured concentration when
no thrombin was present as displayed in Fig. S2.† These control
experiments were conducted 4 times across 4 different days (ESI
Fig. S2†).
During this dispersion assay we have improved upon sensi-
tivity by three orders of magnitude and are able to measure a
signal at 100 fM of thrombin. To enable a comparison between
thesemethods the number of thrombinmolecules per bead and
the percentage signal output elicited for our initial work isper dynabead bead and the average percentage (n ¼ 4)  the range of
%CPC800s
released
%SKP400s
released
2  1 1  0
38  18 20  5
70  17 55  15
100  18 88  14
98  20 100  7
Anal. Methods, 2015, 7, 8534–8538 | 8537
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View Article Onlinedisplayed in Table S1.† Although this proof-of-concept assay
focusses on the measurement of thrombin protein, it would be
possible to easily adapt the assay by simply changing the
aptamer which is conjugated to the bead surface and creating a
matching complementary sequence.
We present the detection of thrombin protein as low as 100
fM concentration. By using superparamagnetic beads it is
possible to easily separate protein-laden beads, which can be
difficult to analyse with pore-based technologies, enabling
rapid analysis and improving run quality. Though we chose
thrombin to act as a proof-of-concept demonstration of the
technique in theory this technique could be easily applied to
any protein of interest for which there is an available aptamer.
As such, this development represents a great advancement in
aptamer-based TRPS assays and could pave the way for sensitive
protein detecting in a sub 5 minute assay.
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